NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors

The standard of care for managing patients with gastrointestinal stromal tumors (GISTs) rapidly changed after the introduction of effective molecularly targeted therapies involving tyrosine kinase inhibitors (TKIs), such as imatinib mesylate and sunitinib malate. A better understanding of the molecu...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Demetri, George D., von Mehren, Margaret, Antonescu, Cristina R., DeMatteo, Ronald P., Ganjoo, Kristen N., Maki, Robert G., Pisters, Peter W.T., Raut, Chandrajit P., Riedel, Richard F., Schuetze, Scott, Sundar, Hema M., Trent, Jonathan C., Wayne, Jeffrey D.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2010
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4103754/
https://ncbi.nlm.nih.gov/pubmed/20457867
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares